Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders
Serhat Tunç, Murat Atagün, Salim Neşelioğlu, Yelda Yenilmez, Hamit Başbuğ, Ozcan Erel
( Psychiatry and Clinical Psychopharmacology 2019; 29: 123-129) DOI: 10.1080/24750573.2018.1517466